What is glycomet and what is it used for?
Glycomet is the generic version of Metformin.
The biggest use for metformin is for the treatment of diabetes mellitus type 2, especially when it is concomitant with podginess and insulin resistance.
It is also being used increasingly surrounded by polycystic ovarian syndrome (PCOS) and non-alcoholic steatohepatitis, two other diseases that feature insulin resistance; these indications are still considered experimental.
Metformin is the one and only anti-diabetic drug that has be proven to reduce the complications of diabetes, as evidenced within a large study of overweight patients near diabetes.
Metformin IR (immediate release) is available in 500 mg and 850 mg tablets. Doses of up to 3 g a morning are commonly prescribed.
Metformin SR (slow release) was introduced within 2004, mainly to counteract the most adjectives side-effects. No difference in glycemic control exists between the two preparations.
Metformin is commonly prescribed to type 2 diabetes patients in combination beside rosiglitazone. This drug actively reduces insulin resistance, complementing the goings-on of the metformin. In 2002, the two drugs were combined into a single product, Avandamet, market by GlaxoSmithKline. In 2005, all current stock of Avandamet be seized by the FDA and removed from the market. This be due to problems at the manufacturing plants, not to any medical issues resulting from the drugs use. The drug duet continued to be prescribed separately in the absenteeism of Avandamet itself, which was close at hand by the end of that year.
It is for diabetics. Glyconutrients enjoy been prven to work better.